0
0
11/30/22 at 2:13pm
Organization
Ajmc.com
46 words
0
Comments
Only 2% of patients with primary sclerosing cholangitis (PSC) received a cholangiocarcinoma diagnosis, and the diagnosis was not early enough for there to be a survival benefit.
You are the first to view
https://www.ajmc.com/view/surveillance-program-ineffective-at-detecting-cholangiocarcinoma-early-enough-for-benefit-in-patients-with-psc
Create an account
or login to join the discussion